Elecsys (R) ProBNP Immunoassay for the diagnosis of congestive heart failure

Bywood, P, Merlin, T, Braunack-Mayer, A, Hiller, J
Record ID 32006000585
Authors' recommendations: Currently Elecsys proBNP is used in hospital settings across Australia. Although the available evidence indicates its usefulness as a rule-out test for congestive heart failure (CHF), positive results should be interpreted with caution, requiring echocardiographic confirmation of CHF before providing treatment. Furthermore, the lack of good quality studies in a community setting limit speculation on the impact of primary care N-terminal brain natriuretic peptide (NT-proBNP) testing on patient outcomes.
Project Status: Completed
Year Published: 2004
URL for published report: Not Available
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Heart Failure
  • Immunoassay
  • Natriuretic Peptide, Brain
  • Peptide Fragments
Organisation Name: Adelaide Health Technology Assessment
Contact Address: School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name: ahta@adelaide.edu.au
Contact Email: ahta@adelaide.edu.au
Copyright: Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.